PL3704143T3 - Chemo-enzymatyczna synteza liraglutydu, semaglutydu i glp-1 - Google Patents

Chemo-enzymatyczna synteza liraglutydu, semaglutydu i glp-1

Info

Publication number
PL3704143T3
PL3704143T3 PL19709061.6T PL19709061T PL3704143T3 PL 3704143 T3 PL3704143 T3 PL 3704143T3 PL 19709061 T PL19709061 T PL 19709061T PL 3704143 T3 PL3704143 T3 PL 3704143T3
Authority
PL
Poland
Prior art keywords
semaglutide
liraglutide
chemo
glp
enzymatic synthesis
Prior art date
Application number
PL19709061.6T
Other languages
English (en)
Inventor
Peter Jan Leonard Mario Quaedflieg
Ana TOPLAK
Timo Nuijens
Original Assignee
Fresenius Kabi Ipsum S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Ipsum S.R.L. filed Critical Fresenius Kabi Ipsum S.R.L.
Publication of PL3704143T3 publication Critical patent/PL3704143T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
PL19709061.6T 2018-03-09 2019-03-11 Chemo-enzymatyczna synteza liraglutydu, semaglutydu i glp-1 PL3704143T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18161084 2018-03-09
PCT/EP2019/056046 WO2019170918A1 (en) 2018-03-09 2019-03-11 Chemo-enzymatic synthesis of liraglutide, semaglutide and glp-1

Publications (1)

Publication Number Publication Date
PL3704143T3 true PL3704143T3 (pl) 2024-04-15

Family

ID=61800262

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19709061.6T PL3704143T3 (pl) 2018-03-09 2019-03-11 Chemo-enzymatyczna synteza liraglutydu, semaglutydu i glp-1

Country Status (9)

Country Link
US (2) US10883132B2 (pl)
EP (1) EP3704143B1 (pl)
JP (2) JP7859790B2 (pl)
KR (1) KR102829589B1 (pl)
CN (2) CN119060201A (pl)
CA (1) CA3093221A1 (pl)
ES (1) ES2962666T3 (pl)
PL (1) PL3704143T3 (pl)
WO (1) WO2019170918A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11421213B2 (en) * 2017-09-05 2022-08-23 Henkel Ag & Co. Kgaa Performance-enhanced protease variants II
SMT202200352T1 (it) 2018-04-05 2022-09-14 Sun Pharmaceutical Ind Ltd Analoghi del glp-1 innovativi
CN110590934B (zh) * 2019-09-25 2020-12-08 北京乐普医药科技有限公司 一种glp-1化合物
EP4146249A4 (en) * 2020-05-05 2024-08-21 Neuland Laboratories Ltd IMPROVED PROCESS FOR THE PREPARATION OF SEMAGLUTIDE
KR20240118914A (ko) 2021-01-20 2024-08-05 바이킹 테라퓨틱스 인코포레이티드 대사 및 간 질환 치료를 위한 조성물 및 방법
US12497644B2 (en) 2021-02-12 2025-12-16 Fresenius Kabi Ipsum S.R.L. Subtilisin variants and their use
CA3231953A1 (en) 2021-09-15 2023-03-23 Brian Lian Compositions and methods for the treatment of metabolic and liver disorders
WO2024133313A1 (en) 2022-12-19 2024-06-27 Enzypep B.V. Thermostable subtilisin variants and their use
WO2024163600A1 (en) * 2023-02-01 2024-08-08 Danisco Us Inc. Subtilisin variants and methods of use
EP4658776A1 (en) * 2023-02-01 2025-12-10 Danisco US Inc. Subtilisin variants and methods of use
WO2025190304A1 (zh) * 2024-03-14 2025-09-18 博瑞生物医药(苏州)股份有限公司 包含glp-1和gip双受体激动剂的药物组合物及其用途
WO2025262181A1 (en) 2024-06-19 2025-12-26 Fresenius Kabi Ipsum S.R.L. Method to improve the producibility of a peptiligase enzyme
WO2026002733A1 (en) * 2024-06-24 2026-01-02 Fresenius Kabi Ipsum S.R.L. Method for the synthesis of a peptide with amino acids having basic side-chains

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE187495T1 (de) 1990-08-09 1999-12-15 Genentech Inc Serinproteasevarianten mit peptidligase aktivität
US5567601A (en) * 1993-06-01 1996-10-22 University Of Maryland Subtilisin mutants lacking a primary calcium binding site
US6451974B1 (en) 1999-03-17 2002-09-17 Novo Nordisk A/S Method of acylating peptides and novel acylating agents
US6541235B1 (en) 2000-09-29 2003-04-01 University Of Maryland Biotechnology Institute Calcium free subtilisin mutants
EP1750752A2 (en) * 2003-11-20 2007-02-14 Neuronova AB Compounds and methods for increasing neurogenesis
MX2008015935A (es) 2006-06-23 2009-01-13 Hoffmann La Roche Sintesis de un peptido insulinotropico.
WO2014199397A2 (en) 2013-06-11 2014-12-18 Mylan Laboratories Ltd Process for the preparation of liraglutide
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
EP3204401A1 (en) 2014-10-10 2017-08-16 Enzypep B.V. Peptide fragment condensation and cyclisation using a subtilisin variant with improved synthesis over hydrolysis ratio
US10752931B2 (en) 2015-07-09 2020-08-25 Enzypep B.V. Designing an enzymatic peptide fragment condensation strategy
WO2018032521A1 (zh) 2016-08-19 2018-02-22 深圳市健元医药科技有限公司 一种利拉鲁肽的合成方法

Also Published As

Publication number Publication date
EP3704143C0 (en) 2023-10-18
JP2021516556A (ja) 2021-07-08
JP7859790B2 (ja) 2026-05-15
CN119060201A (zh) 2024-12-03
KR102829589B1 (ko) 2025-07-04
KR20200130712A (ko) 2020-11-19
CN111819191B (zh) 2024-08-20
US10883132B2 (en) 2021-01-05
WO2019170918A1 (en) 2019-09-12
ES2962666T3 (es) 2024-03-20
EP3704143B1 (en) 2023-10-18
US20190345529A1 (en) 2019-11-14
US10920258B2 (en) 2021-02-16
JP2024010221A (ja) 2024-01-23
CA3093221A1 (en) 2019-09-12
CN111819191A (zh) 2020-10-23
US20200347427A1 (en) 2020-11-05
EP3704143A1 (en) 2020-09-09

Similar Documents

Publication Publication Date Title
ZA202007990B (en) Update of look up table: fifo, constrained fifo
CA188938S (en) Personal vaporizer
MX2020003217A (es) Coagonistas de accion prolongada de los receptores de glucagon y glp-1.
SG11202000940XA (en) Glp-1 compositions and uses thereof
EP3704143C0 (en) CHEMIOENZYMATIC SYNTHESIS OF LIRAGLUTIDE, SEMAGLUTIDE AND GLP-1
IL277483A (en) New anti-GLP-1 analogs
ZA201806637B (en) Glucagon and glp-1 co-agonists for the treatment of obesity
IL272851B (en) Methods for using dipifaprin
GB201803568D0 (en) Novel compounds and uses
GB201804514D0 (en) Treatment of pyroptosis
IL254166A0 (en) Ultrapure dsba and dsbc and methods for their preparation and use
WO2017100107A3 (en) Co-agonists of the glucagon and glp-1 receptors
GB2574074B (en) Time synchronisation
WO2017074798A3 (en) Long-acting co-agonists of the glucagon and glp-1 receptors
SG11202011041YA (en) Combination compositions comprising bisfluoroalkyl-1,4- benzodiazepinone compounds and methods of use thereof
SG11202011227VA (en) Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
GB202204020D0 (en) Cachability of single page application
GB201804515D0 (en) Treatment of necroptosis
ZA202105399B (en) Use of spiropidion
IL276107A (en) Crystalline forms of psoorstam
GB2572173B (en) Personal cleansing composition
HK40034345A (en) Chemo-enzymatic synthesis of semaglutide, liraglutide and glp-1
SG11202105136WA (en) Application of chidamide
IL283421A (en) Crystalline forms of Refroxlap
ZA202005315B (en) Novel promoter and use thereof